Blue Earth Diagnostics is funded by Syncona, an investment company listed on the London Stock Exchange (LON:SYNC). Syncona is a leading FTSE250 healthcare company focussed on investing in and building leaders in life sciences. Syncona’s vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders. Syncona’s investment portfolio consists of seven high quality companies in life science and a leading range of fund investments. Syncona is aligned with two of the premium charitable funders in UK science, the Wellcome Trust, original founder of Syncona, and Cancer Research UK. Syncona makes a donation of 0.3% of Net Asset Value to a range of charities each year.